Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04675710 |
| Title | Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | M.D. Anderson Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Stanford School of Medicine | RECRUITING | Stanford | California | 94304 | United States | Details |
| University of Michigan Rogel Cancer Center | RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |
| Mayo Clinic | RECRUITING | Rochester | Minnesota | 55901 | United States | Details |
| Cleveland Clinic Taussig Cancer Institute | RECRUITING | Cleveland | Ohio | 44195 | United States | Details |
| M D Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
| Huntsman Cancer Institute at the University of Utah | RECRUITING | Salt Lake City | Utah | 84112 | United States | Details |